• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种使用非线性混合模型的新型时-活度信息分享方法,可在减少成像时间点的情况下进行个体化剂量学:Lu-DOTATATE 后 SPECT/CT 的应用。

A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After Lu-DOTATATE.

机构信息

Department of Biostatistics, University of Michigan, Ann Arbor, Michigan;

Department of Radiology, University of Michigan, Ann Arbor, Michigan; and.

出版信息

J Nucl Med. 2021 Aug 1;62(8):1118-1125. doi: 10.2967/jnumed.120.256255. Epub 2020 Dec 18.

DOI:10.2967/jnumed.120.256255
PMID:33443063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8833869/
Abstract

Multiple-time-point SPECT/CT imaging for dosimetry is burdensome for patients and lacks statistical efficiency. A novel method for joint kidney time-activity estimation based on a statistical mixed model, a prior cohort of patients with complete time-activity data, and only 1 or 2 imaging points for new patients was compared with previously proposed single-time-point methods in virtual and clinical patient data. Data were available for 10 patients with neuroendocrine tumors treated with Lu-DOTATATE and imaged up to 4 times between days 0 and 7 using SPECT/CT. Mixed models using 1 or 2 time points were evaluated retrospectively in the clinical cohort, using the multiple-time-point fit as the reference. Time-activity data for 250 virtual patients were generated using parameter values from the clinical cohort. Mixed models were fit using 1 (∼96 h) and 2 (4 h, ∼96 h) time points for each virtual patient combined with complete data for the other patients in each dataset. Time-integrated activities (TIAs) calculated from mixed model fits and other reduced-time-point methods were compared with known values. : All mixed models and single-time-point methods performed well overall, achieving mean bias < 7% in the virtual cohort. Mixed models exhibited lower bias, greater precision, and substantially fewer outliers than did single-time-point methods. For clinical patients, 1- and 2-time-point mixed models resulted in more accurate TIA estimates for 94% (17/18) and 72% (13/18) of kidneys, respectively. In virtual patients, mixed models resulted in more than a 2-fold reduction in the proportion of kidneys with |bias| > 10% (6% vs. 15%). Mixed models based on a historical cohort of patients with complete time-activity data and new patients with only 1 or 2 SPECT/CT scans demonstrate less bias on average and significantly fewer outliers when estimating kidney TIA, compared with popular reduced-time-point methods. Use of mixed models allows for reduction of the imaging burden while maintaining accuracy, which is crucial for clinical implementation of dosimetry-based treatment.

摘要

多次点 SPECT/CT 成像进行剂量测定对患者来说负担很重,而且缺乏统计学效率。一种新的基于统计混合模型、具有完整时间活动数据的先前队列患者和新患者仅 1 或 2 个成像点的联合肾脏时间活动估计新方法与先前提出的单次点方法在虚拟和临床患者数据中进行了比较。10 名神经内分泌肿瘤患者接受 Lu-DOTATATE 治疗,在第 0 天至第 7 天之间使用 SPECT/CT 进行了多达 4 次成像,可获得这些患者的数据。在临床队列中,使用多次点拟合作为参考,对使用 1 个或 2 个时间点的混合模型进行了回顾性评估。使用来自临床队列的参数值为 250 个虚拟患者生成时间活动数据。对于每个虚拟患者,使用 1 个(约 96 小时)和 2 个(4 小时,约 96 小时)时间点拟合混合模型,并与每个数据集的其他患者的完整数据相结合。从混合模型拟合和其他减少时间点的方法计算的时间积分活动(TIA)与已知值进行比较。所有混合模型和单点方法总体上表现良好,在虚拟队列中平均偏差<7%。混合模型的偏差较小,精度较高,异常值明显少于单点方法。对于临床患者,1 点和 2 点混合模型分别导致 94%(17/18)和 72%(13/18)的肾脏 TIA 估计值更准确。在虚拟患者中,混合模型导致具有|偏差|>10%(6%比 15%)的肾脏比例降低了两倍多。基于具有完整时间活动数据的历史队列患者和仅进行 1 或 2 次 SPECT/CT 扫描的新患者的混合模型在估计肾脏 TIA 时平均偏差较小,异常值明显较少,与流行的减少时间点方法相比。使用混合模型可以减少成像负担,同时保持准确性,这对于基于剂量测定的治疗的临床实施至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b33/8833869/b2c29370af71/jnm256255absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b33/8833869/b2c29370af71/jnm256255absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b33/8833869/b2c29370af71/jnm256255absf1.jpg

相似文献

1
A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After Lu-DOTATATE.一种使用非线性混合模型的新型时-活度信息分享方法,可在减少成像时间点的情况下进行个体化剂量学:Lu-DOTATATE 后 SPECT/CT 的应用。
J Nucl Med. 2021 Aug 1;62(8):1118-1125. doi: 10.2967/jnumed.120.256255. Epub 2020 Dec 18.
2
Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a Lu-DOTATATE patient study.使用简化时间活性曲线建模方法进行的肾脏剂量测定的准确性:Lu-DOTATATE 患者研究。
Phys Med Biol. 2019 Aug 28;64(17):175006. doi: 10.1088/1361-6560/ab3039.
3
Deep transformer-based personalized dosimetry from SPECT/CT images: a hybrid approach for [Lu]Lu-DOTATATE radiopharmaceutical therapy.基于深度变压器的SPECT/CT图像个性化剂量测定:[Lu]Lu-DOTATATE放射性药物治疗的混合方法
Eur J Nucl Med Mol Imaging. 2024 May;51(6):1516-1529. doi: 10.1007/s00259-024-06618-9. Epub 2024 Jan 25.
4
Single-Time-Point Imaging for Dosimetry After [Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point Selection.单次成像在[Lu]Lu-DOTATATE 后剂量学中的应用:降低时间点选择敏感性的现有方法和新的数据驱动模型的准确性。
J Nucl Med. 2023 Sep;64(9):1463-1470. doi: 10.2967/jnumed.122.265338. Epub 2023 Jul 27.
5
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [Lu]Lu-DOTATATE.[镥]镥-DOTATATE 治疗神经内分泌肿瘤的吸收剂量与反应的关系。
J Nucl Med. 2024 Jul 1;65(7):1070-1075. doi: 10.2967/jnumed.123.266991.
6
A dosimetry procedure for organs-at-risk in Lu peptide receptor radionuclide therapy of patients with neuroendocrine tumours.用于神经内分泌肿瘤患者 Lu 肽受体放射性核素治疗中危险器官的剂量学程序。
Phys Med. 2018 Dec;56:41-49. doi: 10.1016/j.ejmp.2018.11.001. Epub 2018 Nov 22.
7
Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for Lu-DOTATATE PRRT in patients and clinically realistic simulations.镥-奥曲肽肽受体放射性核素治疗(Lu-DOTATATE PRRT)中,减少时间点成像对患者时间积分活度及临床真实模拟的准确性和不确定性分析。
EJNMMI Res. 2023 Jun 12;13(1):57. doi: 10.1186/s13550-023-01007-z.
8
A radiomic- and dosiomic-based machine learning regression model for pretreatment planning in Lu-DOTATATE therapy.基于放射组学和剂量组学的机器学习回归模型,用于 Lu-DOTATATE 治疗的预处理规划。
Med Phys. 2023 Nov;50(11):7222-7235. doi: 10.1002/mp.16746. Epub 2023 Sep 18.
9
Accuracy and uncertainty analysis of reduced time point imaging effect on time-integrated activity for 177Lu-DOTATATE PRRT in clinical patients and realistic simulations.177Lu-DOTATATE肽受体放射性核素治疗中临床患者及真实模拟条件下,减少时间点成像对时间积分活度的影响的准确性和不确定性分析
Res Sq. 2023 Apr 21:rs.3.rs-2829731. doi: 10.21203/rs.3.rs-2829731/v1.
10
SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [Lu]Lu-DOTATATE.SPECT/CT 图像衍生的红骨髓吸收剂量与接受 [Lu]Lu-DOTATATE 治疗的患者的血液学毒性相关。
J Nucl Med. 2024 May 1;65(5):753-760. doi: 10.2967/jnumed.123.266843.

引用本文的文献

1
Digital twins in nuclear medicine: A proposition of a modular pipeline for dosimetry protocol optimization in molecular radiotherapy.核医学中的数字孪生:分子放射治疗中剂量测定方案优化的模块化流程建议。
Comput Struct Biotechnol J. 2025 Aug 27;28:306-311. doi: 10.1016/j.csbj.2025.08.027. eCollection 2025.
2
Framework to calculate Ac, Lu, and Tb radiation dose and biological effect in metastatic castration-resistant prostate cancer treatment.计算转移性去势抵抗性前列腺癌治疗中Ac、Lu和Tb辐射剂量及生物学效应的框架。
Med Phys. 2025 Aug;52(8):e18035. doi: 10.1002/mp.18035.
3
Non-linear mixed-effects modelling and population-based model selection for I kinetics in benign thyroid disease.

本文引用的文献

1
Influence of sampling schedules on [Lu]Lu-PSMA dosimetry.采样计划对[镥]镥-PSMA剂量测定的影响。
EJNMMI Phys. 2020 Jun 17;7(1):41. doi: 10.1186/s40658-020-00311-0.
2
Radiation Dosimetry in Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors.使用单次治疗后 SPECT/CT 扫描进行 Lu-PSMA-617 治疗中的辐射剂量测定:一种生成时间和组织特异性剂量因子的新方法。
J Nucl Med. 2020 Jul;61(7):1030-1036. doi: 10.2967/jnumed.119.233411. Epub 2019 Dec 5.
3
Technical Note: Optimal sampling schedules for kidney dosimetry based on the hybrid planar/SPECT method in Lu-PSMA therapy.
良性甲状腺疾病中碘动力学的非线性混合效应建模与基于群体的模型选择
EJNMMI Phys. 2025 Apr 8;12(1):37. doi: 10.1186/s40658-025-00735-6.
4
Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning.使用机器学习对即时单时间点剂量测定的有效半衰期进行表征。
J Nucl Med. 2025 May 1;66(5):778-784. doi: 10.2967/jnumed.124.268175.
5
A Pharmacokinetic Model Determination of Time Activity Curves in Radiopharmaceutical Therapy.放射性药物治疗中时间-活度曲线的药代动力学模型测定
Mol Imaging. 2024 Nov 3;23:15353508241280015. doi: 10.1177/15353508241280015. eCollection 2024 Jan-Dec.
6
Prediction of 1 cm dose-equivalent rate on the day after administration of Lu-DOTATATE from In-somatostatine receptor scintigraphy prior to treatment.治疗前应用生长抑素受体闪烁显像预测 Lu-DOTATATE 给药后第 1 天的 1cm 剂量当量率。
Ann Nucl Med. 2024 Nov;38(11):927-932. doi: 10.1007/s12149-024-01962-0. Epub 2024 Jul 26.
7
Estimation of kidney doses from [Lu]Lu-DOTA-TATE PRRT using single time point post-treatment SPECT/CT.使用治疗后单时间点SPECT/CT估计[镥]镥-多柔比星-奥曲肽肽受体放射性核素治疗的肾脏剂量。
EJNMMI Phys. 2024 Jul 25;11(1):68. doi: 10.1186/s40658-024-00665-9.
8
A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?177镥剂量测定工作流程综述:如何减少成像工作量?
EJNMMI Phys. 2024 Jul 18;11(1):65. doi: 10.1186/s40658-024-00658-8.
9
Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [Lu]Lu-PSMA-I&T Therapy.参考多时间点剂量测定方案对[镥]镥-PSMA-I&T治疗单次时间点剂量测定有效性的影响。
J Nucl Med. 2024 Aug 1;65(8):1272-1278. doi: 10.2967/jnumed.123.266871.
10
Uncertainty Analysis of Time-Integrated Activity Coefficient in Single-Time-Point Dosimetry Using Bayesian Fitting Method.使用贝叶斯拟合方法对单时间点剂量测定中时间积分活度系数的不确定性分析
Nucl Med Mol Imaging. 2024 May;58(3):120-128. doi: 10.1007/s13139-024-00851-8. Epub 2024 Feb 23.
技术说明:基于 Lu-PSMA 治疗的混合平面/SPECT 方法的肾脏剂量测定的最佳采样方案。
Med Phys. 2019 Dec;46(12):5861-5866. doi: 10.1002/mp.13846. Epub 2019 Oct 29.
4
Accuracy of kidney dosimetry performed using simplified time activity curve modelling methods: a Lu-DOTATATE patient study.使用简化时间活性曲线建模方法进行的肾脏剂量测定的准确性:Lu-DOTATATE 患者研究。
Phys Med Biol. 2019 Aug 28;64(17):175006. doi: 10.1088/1361-6560/ab3039.
5
Feasibility and accuracy of single time point imaging for renal dosimetry following Lu-DOTATATE ('Lutate') therapy.镥[¹⁷⁷Lu]奥曲肽(“Lutate”)治疗后肾剂量测定单次时间点成像的可行性和准确性。
EJNMMI Phys. 2018 Dec 20;5(1):33. doi: 10.1186/s40658-018-0232-9.
6
Accuracy and reproducibility of simplified QSPECT dosimetry for personalized Lu-octreotate PRRT.用于个性化镥-奥曲肽肽受体放射性核素治疗的简化QSPECT剂量测定法的准确性和可重复性。
EJNMMI Phys. 2018 Oct 15;5(1):25. doi: 10.1186/s40658-018-0224-9.
7
Characterization of Noise and Resolution for Quantitative Lu SPECT/CT with xSPECT Quant.定量 Lu SPECT/CT 与 xSPECT Quant 的噪声和分辨率特性。
J Nucl Med. 2019 Jan;60(1):50-59. doi: 10.2967/jnumed.118.211094. Epub 2018 Jul 5.
8
Feasibility of simplifying renal dosimetry in Lu peptide receptor radionuclide therapy.简化镥肽受体放射性核素治疗中肾脏剂量测定的可行性。
EJNMMI Phys. 2018 Jul 5;5(1):12. doi: 10.1186/s40658-018-0210-2.
9
Technical Note: Single time point dose estimate for exponential clearance.技术说明:指数廓清的单点剂量估计。
Med Phys. 2018 May;45(5):2318-2324. doi: 10.1002/mp.12886. Epub 2018 Apr 16.
10
Kidney dosimetry during Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and tolerance.在神经内分泌肿瘤患者的 Lu-DOTATATE 治疗期间的肾脏剂量学:计算和耐受方面。
Acta Oncol. 2018 Apr;57(4):516-521. doi: 10.1080/0284186X.2017.1378431. Epub 2017 Sep 18.